Treatment of epilepsy with topiramate: Analysis of 12- and 24-month treatment in 98 patients;Epilepsietherapie mit topiramat: Eine 12- und 24-monatige behandlungsanalyse von 98 patienten

Aktuelle Neurologie

Volumn 34, Issue 10, 2007, Pages 555-558

  Beerlage, S ^a   Bauer, Jürgen ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Antiepileptic drugs; Epilepsy; Topiramate

Indexed keywords

TOPIRAMATE;

AGE DISTRIBUTION; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; DISEASE DURATION; DRUG EFFICACY; EPILEPSY; FOLLOW UP; HUMAN; MENTAL DISEASE; SEX RATIO; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 40849088406     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-986225     Document Type: Article

References (15)

1. Brodie MJ, Kwan P. Staged approach to epilepsy management. Neurology 2002; 58 (Suppl 5): S2-S8
2. Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007, epub ahead of print
3. Bauer J, Schwalen S. Topiramat (Topamax). Nervenarzt 2000; 71: 495-501
4. Bauer J, Ruocco A. Pregabalin zur Kombinationsbehandlung von fokalen Epilepsien. Analyse des Behandlungsverlaufs von 103 Patienten. Akt Neurol 2006; 33: 439-441
5. Chahem J, Bauer J. Epilepsietherapie mit Antiepileptika der dritten Wahl: Felbamat, Tiagabin und Sultiam. Nervenarzt 2007, epub ahead of print
6. Bootsma HP, Ricker L, Diepman L et al. Long-term effects of levetiracetam and topiramate in clinical practice: a head-to-head comparison. Seizure 2007, epub ahead of print
7. Krakow K, Lengler U, Rettig K et al. Topiramate in add-on therapy: Results from an open-label, observational study. Seizure 2007; 16: 593-600
8. Majkowski J, Neto W, Wapenaar R, van Oene J. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine. Epilepsia 2005; 46: 648-653
9. Bös M, Bauer J. Antikonvulsive Komedikation von Topiramat und Zonisamid. Eine erste Analyse der Verträglichkeit bei 19 Patienten. Nervenarzt, 2007 (im Druck)
10. Cheung E, Wong V, Fung CW. Topiramte-valproate-induced hyperammonemic encephalopathy syndrome: case report. J Child Neurol 2005; 20: 157-160
11. Hamer HM, Knake S, Schomburg U, Rosenow F. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 2000; 54: 230-232
12. Bauer J, Burr W. Course of chronic focal epilepsy resistant to anticonvulsant treatment. Seizure 2001; 10: 239-246
13. Bauer J, Buchmüller L, Reuber M, Burr W. Which patients becomes seizure-free with antiepileptic drugs? An observational study in 821 patients with epilepsy. Acta Neurol Scand, (in press)
14. Bauer J, Ben-Menachem E, Krämer G et al. Levetiracetam: a long-term follow-up study of efficacy and safety. Acta Neurol Scand 2006; 114: 169-176
15. Bauer J. Epilepsietherapie im Erwachsenenalter. Optionen und Strategien. Nervenarzt 2007; 78 (Suppl 1): 27-36